P3 Health Partners Inc

Análisis de la acción P3 Health Partners Inc (PIII)

$4.010

+0.199 (+4.97%)Al cierre

Loading chart…
Máximo
4.100
Apertura
3.970
Precio medio ponderado por volumen
4.03
Volumen
7.11K
Capitalización
91.20M
Mínimo
3.970
Importe
28.62K
EV/EBITDA, TTM
3.35

P3 Health Partners Inc. is a patient-centered and physician-led population health management company. The Company supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, it creates an enhanced patient experience by navigating, coordinating, and integrating the patient’s care within the healthcare system. Its technology platform, P3 Technology/Health Hub, enables physicians, care teams, patients and their family members to engage in the care journey. P3 Technology/Health Hub integrates clinical and claims data from disparate data points each month from payors, outpatient and inpatient facilities and other ancillary care settings. It has a network of more than 3,100 affiliated primary care providers across the country. Its local teams of healthcare professionals manage the care of thousands of patients in 27 counties across five states.

ir.p3hp.org

Análisis de IA of P3 Health Partners Inc (PIII)

Comprar

P3 Health Partners Inc. appears to be a good buy right now due to its recent turnaround in profitability, reporting a net income of $15.7 million in Q2 2026, a significant recovery from a loss of $43.7 million the previous year. Additionally, the stock is currently priced at $4.01, which is significantly lower than its 52-week high of $16.89, suggesting potential for upside. The forward P/E ratio is at 0, indicating that the stock is undervalued based on future earnings expectations. However, the main risk lies in its current debt situation, with a debt-to-equity ratio of 94.64%, which could impact financial stability if not managed properly.

Métricas de valoración

El PER previsto actual de P3 Health Partners Inc (PIII) es 0.00, frente a su media de 5 años de -3.14.

PER previsto

Valor razonable
Media 5A P/E
-3.14
P/E actual
0.00
Sobrevalorada
3.05
Infravalorada
-9.34

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
-2.05
EV/EBITDA actual
3.35
Sobrevalorada
90.93
Infravalorada
-95.03

Precio/ventas previsto

Muy sobrevalorado
Media 5A P/S
0.13
P/S actual
0.46
Sobrevalorada
0.24
Infravalorada
0.02

Escenarios de precio de Alphio AI para PIII

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%PIII

$8.18

Precio del escenario

B

Base

Base · 50%PIII

$7.60

Precio del escenario

B

Bajista

Bajista · 25%PIII

$6.61

Precio del escenario

Cronología de eventos

2026-10-15 (ET)

06:30:00

Selling Stockholders Plan to Sell 15.64M Shares of Class A Common Stock

2026-10-12 (ET)

09:30:00

P3 Health Partners Appoints Dr. Michael Millie as Chief Clinical Officer

2026-08-10 (ET)

16:30:00

Sees FY26 Adjusted EBITDA of $80M-$110M

16:30:00

P3 Reports Q2 Revenue of $386.38M, Beating Expectations

2026-05-19 (ET)

10:00:00

P3 Health Partners Inc Trading Resumes

Noticias

Preguntas frecuentes sobre PIII, respondidas por Alphio AI

P3 Health Partners Inc. is a patient-centered and physician-led population health management company. The Company supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, it creates an enhanced patient experience by navigating, coordinating, and integrating the patient’s care within the healthcare system. Its technology platform, P3 Technology/Health Hub, enables physicians, care teams, patients and their family members to engage in the care journey. P3 Technology/Health Hub integrates clinical and claims data from disparate data points each month from payors, outpatient and inpatient facilities and other ancillary care settings. It has a network of more than 3,100 affiliated primary care providers across the country. Its local teams of healthcare professionals manage the care of thousands of patients in 27 counties across five states. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).

P3 Health Partners Inc. appears to be a good buy right now due to its recent turnaround in profitability, reporting a net income of $15.7 million in Q2 2026, a significant recovery from a loss of $43.7 million the previous year. Additionally, the stock is currently priced at $4.01, which is significantly lower than its 52-week high of $16.89, suggesting potential for upside. The forward P/E ratio is at 0, indicating that the stock is undervalued based on future earnings expectations. However, the main risk lies in its current debt situation, with a debt-to-equity ratio of 94.64%, which could impact financial stability if not managed properly.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Artículos relacionados

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar